Screening and Treatment for Major Depressive Disorder in Children and Adolescents: US Preventive Services Task Force Recommendation Statement

This is an update of the 2002 US Preventive Services Task Force recommendation on screening for child and adolescent major depressive disorder. The US Preventive Services Task Force weighed the benefits and harms of screening and treatment for major depressive disorder in children and adolescents, i...

Full description

Saved in:
Bibliographic Details
Published in:Pediatrics (Evanston) 2009-04, Vol.123 (4), p.1223-1228
Main Author: US Preventive Services Task Force
Format: Article
Language:English
Subjects:
Adolescent
Adult and adolescent clinical studies
Age Factors
Biological and medical sciences
Care and treatment
Child
Childhood depression
Demographic aspects
Depression
Depression in children
Depressive Disorder, Major - diagnosis
Depressive Disorder, Major - drug therapy
Depressive Disorder, Major - therapy
Diagnosis
General aspects
Health Status Indicators
Humans
Major depressive disorder
Mass Screening
Medical sciences
Mood disorders
Neuropsychological Tests
Prevention and actions
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Psychotherapy
Public health. Hygiene
Public health. Hygiene-occupational medicine
Risk Assessment
Serotonin Uptake Inhibitors - therapeutic use
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This is an update of the 2002 US Preventive Services Task Force recommendation on screening for child and adolescent major depressive disorder. The US Preventive Services Task Force weighed the benefits and harms of screening and treatment for major depressive disorder in children and adolescents, incorporating new evidence addressing gaps in the 2002 recommendation statement. Evidence examined included the benefits and harms of screening, the accuracy of primary care-feasible screening tests, and the benefits and risks of treating depression by using psychotherapy and/or medications in patients aged 7 to 18 years. Screen adolescents (12-18 years of age) for major depressive disorder when systems are in place to ensure accurate diagnosis, psychotherapy (cognitive-behavioral or interpersonal), and follow-up (B recommendation). Evidence is insufficient to warrant a recommendation to screen children (7-11 years of age) for major depressive disorder (I statement).
ISSN:0031-4005
1098-4275
DOI:10.1542/peds.2008-2381